FDA Drug Recalls

Recalls / Class II

Class IID-0511-2018

Product

Naltrexone HCl USP (Dihydrate) for prescription compounding, packaged in a) 1g (NDC 58597-8407-1); b) 5g (NDC 58597-8407-2); c) 25g (NDC 58597-8407-4); d) 100g (NDC 58597-8407-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Affected lot / code info
Lot #: a) 120916-1, Exp. 10/31/2019; b) 120916-1, Exp. 10/31/2019 c) 120916-1, Exp. 10/31/2019; d) 120916-1, Exp. 10/31/2019.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Recalling firm

Firm
American Pharmaceutical Ingredients LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
6650 Highland Rd Ste 302, N/A, Waterford, Michigan 48327-1665

Distribution

Quantity
7000 g
Distribution pattern
Nationwide within USA.

Timeline

Recall initiated
2018-02-09
FDA classified
2018-02-22
Posted by FDA
2018-02-28
Terminated
2019-12-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0511-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.